| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Medical Officer
1 company
Kim Dennis D is a Chief Medical Officer at Larimar Therapeutics, Inc.. Recent SEC Form 4 filings include 3 buys and 3 sells.
Estimated insider holdings value: $87K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jul 11, 2017 | LRMR Larimar Therapeutics, Inc. | Chief Medical Officer | Buy | 10,000 | $3.39 | $33,900.00 | +87.4% | |
| May 11, 2017 | LRMR Larimar Therapeutics, Inc. | Chief Medical Officer | Buy | 10,000 | $4.40 | $44,000.00 | +324.0% | |
| Sep 17, 2015 | LRMR Larimar Therapeutics, Inc. | Chief Medical Officer | Sale+OE | 39,407 | $40.00 | $1,576,280.00 | -100% | |
| Sep 14, 2015 | LRMR Larimar Therapeutics, Inc. | Chief Medical Officer | Sale+OE | 593 | $40.00 | $23,720.00 | -100% |